CinCor Pharma Statistics
Share Statistics
CinCor Pharma has 43.76M
shares outstanding. The number of shares has increased by 0%
in one year.
| 43.76M |
| 0% |
| 0% |
| n/a |
| 17.91M |
| 4,432 |
| 0.71% |
Short Selling Information
The latest short interest is 486.15K, so 0% of the outstanding
shares have been sold short.
| 486.15K |
| n/a |
| 2.87% |
| 1.99 |
Valuation Ratios
The PE ratio is -11.26 and the forward
PE ratio is null.
CinCor Pharma's PEG ratio is
-0.23.
| -11.26 |
| n/a |
| 0 |
| n/a |
| -8.89 |
| -18.37 |
| -0.23 |
Financial Ratio History Enterprise Valuation
Currently the Enterprise Value (EV) is not available for CinCor Pharma.
| n/a |
| n/a |
| n/a |
| n/a |
Financial Position
The company has a current ratio of 8.53,
with a Debt / Equity ratio of 0.
| 8.53 |
| 8.53 |
| 0 |
| n/a |
| n/a |
| 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| n/a |
| n/a |
| n/a |
| n/a |
| $-2.65M |
| 19 |
| 0 |
| n/a |
Taxes
| -21.64K |
| 0.04% |
Stock Price Statistics
The stock price has increased by 0% in the
last 52 weeks. The beta is 0, so CinCor Pharma's
price volatility has been lower than the market average.
| 0 |
| n/a |
| 22.81 |
| 24.66 |
| 69.26 |
| 625,748 |
Income Statement
| n/a |
| n/a |
| -42.51M |
| -50.35M |
| -34.63M |
| -42.51M |
| -1.42 |
Full Income Statement Balance Sheet
The company has 136.61M in cash and 0 in
debt, giving a net cash position of 136.61M.
| 136.61M |
| n/a |
| n/a |
| -77.7M |
| 529.12M |
| 518.84M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -30.85M
and capital expenditures 0, giving a free cash flow of -30.85M.
| -30.85M |
| n/a |
| -30.85M |
| -0.87 |
Full Cash Flow Statement Margins
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |